Dermatology Times 2018 Insight


Dr. Ioannides is a dedicated dermatologist serving the prominent Treasure Coast Dermatology medical center. Having attended the University of Miami in the school of medicine, Dr. Ioannides enrolled in the University of Florida school of medicine to complete his internship. He Holds a professional certificate of recognition from the American Board of Dermatology.

Dr. Tim Ioannides joined Treasure Coast Dermatology center over fifteen years ago. He works passionately to create a positive impact for the cancer patients and set a legacy for the hospital he co-founded. His dedication includes helping various charitable organizations as a way of giving back to society. Dr. Tim Ioannides is concerned with the future dermatologists hence strives to educate those interested in his career line by serving as a voluntary Associate lecturer at the University of Miami specifically the School of Medicine. He has transformed the lives of many young generations.

Treasure Coast Dermatology has been recognized in the Dermatology Times newspaper that provides significant information to all the readers and creates insight to increase expertise and advance practice. Recently, Dermatology Times acknowledged all their readers by creating a summary list of topics featured in 2018. Some of these top topics featured include Dr. Zoe Diana Draelos advice on how to protect the skin.

She recommends various skin care products for skin rashes and spots. Besides, Dr. Zoe advice people with diseased skin to use cosmetic oils as cleaners to attain pleasing results. Other top stories include the story of;

  • A young child with 8- years who had a sore throat, deep red tongue, petechial rash, and fever symptoms.
  • Numerous images of cases of dermatology treated in 2018.
  • Individualized biological therapy
  • The issue of 493, 204 unused opioid pills that feature the study conducted by a group of dermatologists.
  • Treatment methods for plaque psoriasis, Melasma, and hyperpigmentation.


View Additional Info Here.